Showing 1 - 20 results of 41 for search 'Mu‐Sheng Zeng', query time: 0.06s Refine Results
  1. 1
    Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis

    Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis by Chu Xie, Cong Sun, Mu-Sheng Zeng

    Published 2024-02-01
    Get full text
    Article
  2. 2
    The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

    The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development by Cong Sun, Xin-chun Chen, Yin-feng Kang, Mu-sheng Zeng

    Published 2021-06-01
    Get full text
    Article
  3. 3
    How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection

    How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection by Guo-Long Bu, Chu Xie, Yin-Feng Kang, Mu-Sheng Zeng, Cong Sun

    Published 2022-10-01
    Get full text
    Article
  4. 4
    Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants

    Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants by Cong Sun, Chu Xie, Guo-Long Bu, Lan-Yi Zhong, Mu-Sheng Zeng

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients.

    Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients. by Yang-Yang Li, Sha Fu, Xiao-Pai Wang, Hai-Yun Wang, Mu-Sheng Zeng, Jian-Yong Shao

    Published 2013-01-01
    Get full text
    Article
  6. 6
    EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation.

    EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation. by Xiaoting Xu, Nannan Zhu, Junming Zheng, Yingying Peng, Mu-Sheng Zeng, Kai Deng, Chaohui Duan, Yan Yuan

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma

    Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma by Qian-Ying Zhu, Xiang-Wei Kong, Cong Sun, Shang-Hang Xie, Allan Hildesheim, Su-Mei Cao, Mu-Sheng Zeng

    Published 2020-12-01
    Get full text
    Article
  8. 8
    A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma

    A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma by Yan Mei, Chao Zhou, Chao-Yong Liang, Guan-Ming Lu, Mu-Sheng Zeng, Jin-Jin Wang, Guo-Kai Feng

    Published 2020-01-01
    Get full text
    Article
  9. 9
    Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

    Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma by Qian‐Ying Zhu, Ge‐Xin Zhao, Yan Li, Girish Talakatta, Hai‐Qiang Mai, Quynh‐Thu Le, Lawrence S. Young, Mu‐Sheng Zeng

    Published 2021-06-01
    Get full text
    Article
  10. 10
    Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma.

    Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. by Zi-Chen Zhang, Yang-Yang Li, Hai-Yun Wang, Sha Fu, Xiao-Pai Wang, Mu-Sheng Zeng, Yi-Xin Zeng, Jian-Yong Shao

    Published 2014-01-01
    Get full text
    Article
  11. 11
    A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus

    A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus by Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Qinjian Zhao, Yixin Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Miao Xu, Xiao Zhang

    Published 2022-11-01
    Get full text
    Article
  12. 12
    Urgency and necessity of Epstein-Barr virus prophylactic vaccines

    Urgency and necessity of Epstein-Barr virus prophylactic vaccines by Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Yixin Chen, Qinjian Zhao, Mu-Sheng Zeng, Yi-Xin Zeng, Miao Xu, Xiao Zhang

    Published 2022-12-01
    Get full text
    Article
  13. 13
    The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma.

    The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. by Xiao-Jing Du, Ling-Long Tang, Yan-Ping Mao, Ying Sun, Mu-Sheng Zeng, Tie-Bang Kang, Wei-Hua Jia, Ai-Hua Lin, Jun Ma

    Published 2014-01-01
    Get full text
    Article
  14. 14
    Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding

    Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding by Zhao-Ming Zhong, Xue Chen, Xiao Qi, Xue-Min Wang, Chun-Yan Li, Ru-Jia Qin, Shi-Qi Wang, Jin Liang, Mu-Sheng Zeng, Chuan-Zheng Sun

    Published 2020-01-01
    Get full text
    Article
  15. 15
    Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.

    Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients. by Tian-Run Liu, Li-Hua Xu, An-Kui Yang, Qian Zhong, Ming Song, Man-Zhi Li, Li-Juan Hu, Fu-Jin Chen, Ze-Dong Hu, Ping Han, Mu-Sheng Zeng

    Published 2012-01-01
    Get full text
    Article
  16. 16
    Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants

    Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants by Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, Zheng Liu, Yi-Hao Liu, Sui Peng, Run-Yu Yuan, Jin-Cun Zhao, Mu-Sheng Zeng

    Published 2022-05-01
    Get full text
    Article
  17. 17
    Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

    Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants by Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng, Zheng Liu, Mu-Sheng Zeng

    Published 2022-02-01
    Get full text
    Article
  18. 18
    Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma

    Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma by Yu Wang, Qi Huang, Wan-Li Liu, Meng Wu, Xiao-hui Li, Mu-Sheng Zeng, Ya-Xian Wu, Shan Xing, Bo-Yu Tian, Xue-Ping Wang, Xia He, Shu-Lin Chen

    Published 2023-08-01
    Get full text
    Article
  19. 19
    Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinomaResearch in context

    Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinomaResearch in context by Shang-Xin Liu, Chong Wang, Ruo-Bin Lin, Wei-Yue Ding, Gaurab Roy, Hong-Bo Wang, Ting Yang, Qian Liu, Yi-Ling Luo, Shui-Lin Jin, Mu-Sheng Zeng, Bo Zhao, Qian Zhong

    Published 2023-12-01
    Get full text
    Article
  20. 20
    EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells.

    EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. by Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang

    Published 2023-05-01
    Get full text
    Article

Search Tools: